Back
Procter & Gamble Co. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
43
PG
Procter & Gamble Co.
Last Price:
$144.56
Seasonality Move:
-1.1%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$36.08
Seasonality Move:
-22.7%
Sell
43
Procter & Gamble Co. (PG)
is a Sell
Is Procter & Gamble Co. a Buy, Sell or Hold?
-
The current Procter & Gamble Co. [PG] share price is $144.57. The Score for PG is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
PG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $36.05. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PG Stock Price Chart
What is Procter & Gamble Co.'s stock price today?
-
The Procter & Gamble Co. share price today is $144.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PG is experiencing slight buying pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $36.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight buying pressure.
PG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 40.05 | Buy |
| Relative Strength Index (14 RSI): | 48.54 | Sell |
| Chaikin Money Flow: | 851347 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (141.84 - 147.82) | Sell |
| Bollinger Bands (100): | (145.65 - 156.13) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.11 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 30003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.49 - 35.13) | Buy |
| Bollinger Bands (100): | (10.87 - 25.69) | Buy |
PG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.68 | Sell |
| 20-day SMA: | 143.9 | Buy |
| 50-day SMA: | 146.89 | Sell |
| 200-day SMA: | 156.38 | Sell |
| 8-day EMA: | 125.09 | Buy |
| 20-day EMA: | 79.64 | Buy |
| 50-day EMA: | 39.61 | Buy |
| 200-day EMA: | 11.12 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.28 | Buy |
| 20-day SMA: | 31 | Buy |
| 50-day SMA: | 23.25 | Buy |
| 200-day SMA: | 13.99 | Buy |
| 8-day EMA: | 35.25 | Buy |
| 20-day EMA: | 31.52 | Buy |
| 50-day EMA: | 25.41 | Buy |
| 200-day EMA: | 18.18 | Buy |
Procter & Gamble Co. Earnings Growth & PG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.23 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Procter & Gamble Co. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||